+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Tissue Diagnostics Market by Product Type, Application, Technology, End User - Global Forecast to 2030- Product Image
Tissue Diagnostics Market by Product Type, Application, Technology, End User - Global Forecast to 2030- Product Image
Sale

Tissue Diagnostics Market by Product Type, Application, Technology, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989888
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Tissue diagnostics is rapidly establishing itself as a cornerstone in modern healthcare delivery, facilitating accurate and timely pathology insights that guide therapeutic strategies across diverse clinical settings and research enterprises. The landscape is shaped by ongoing integration of digital technologies, molecular biology, and advanced imaging—all of which are essential considerations for senior decision-makers intent on navigating this evolving sector efficiently.

Market Snapshot: Tissue Diagnostics Market Growth and Key Dynamics

The Tissue Diagnostics Market grew from USD 8.94 billion in 2024 to USD 9.66 billion in 2025. It is expected to continue growing at a CAGR of 7.79%, reaching USD 14.03 billion by 2030. Expansion is underpinned by ongoing innovation in imaging, data analytics, and sample processing, which continues to transform clinical workflows and drive adoption across hospitals, research facilities, and biopharma organizations.

Scope & Segmentation Across Regions, Applications, and Technologies

This report provides a detailed analysis of the tissue diagnostics market, mapping both current and emerging areas:

  • Product Types: Instruments (analyzers & scanners, microscopes), reagents & kits (DNA/RNA probes, enzymes & buffers, staining reagents), and a spectrum of service models including contract research and custom assay development.
  • Applications: Cell imaging and analysis (digital image analysis, fluorescence microscopy), companion diagnostics (targeted therapy selection, efficacy monitoring), infectious disease (bacterial and viral detection), and tumor profiling (gene expression, mutation detection).
  • Technologies: Flow cytometry (automated/benchtop cytometers), immunohistochemistry (chromogenic, fluorescent), in situ hybridization (CISH, FISH), and high-throughput platforms such as microarray and next-generation sequencing.
  • End Users: Academic and community hospitals, diagnostic laboratories, pharmaceutical and biotech companies, government laboratories, and private research institutes.
  • Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, UAE, South Africa), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Southeast Asia).
  • Key Companies: Thermo Fisher Scientific Inc., Danaher Corporation, Roche Diagnostics International AG, Agilent Technologies, Inc., QIAGEN N.V., Merck KGaA, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Sakura Finetek U.S.A., Inc., and GE Healthcare UK Limited.

Tissue Diagnostics Market: Key Takeaways for Decision-Makers

  • Advances in high-resolution imaging, AI-driven image analytics, and digital pathology are enabling labs to improve throughput, accuracy, and turnaround times for tissue-based testing.
  • Companion diagnostics, particularly in oncology and infectious disease, are shaping the trend toward patient-specific, biomarker-driven approaches.
  • Strategic collaborations between device manufacturers and assay developers are accelerating holistic, interoperable workflow solutions that minimize manual errors and reduce operational complexity.
  • Growth in regional manufacturing and supply chain agility is a direct response to tariff impacts and regulatory shifts, supporting continued access to critical reagents and instrumentation.
  • End users—ranging from large hospitals to specialized research labs—are leveraging technology for both high-volume clinical screening and custom assay development, reflecting the diverse needs within the marketplace.
  • Continuous investment in staff training and data integration capabilities helps organizations adapt quickly to evolving protocol, technology, and compliance requirements within the tissue diagnostics sector.

Tariff Impacts and Supply Chain Realignment

Recent harmonized tariffs on imported diagnostic instruments and reagents are introducing new costs and logistical complexities, particularly within the US market. In response, organizations are scaling domestic production, diversifying supplier portfolios, and redesigning procurement strategies. Multivendor architectures and contract renegotiations are becoming standard approaches to maintain cost control and operational continuity with minimal service disruptions.

Methodology & Data Sources

This analysis synthesizes findings from peer-reviewed academic literature, industry white papers, regulatory filings, and authoritative trade registries. Primary insights were substantiated through executive interviews and stakeholder workshops representing diverse expertise across instrument development, clinical operations, and contract research services.

Why This Report Matters

  • Gain a 360-degree perspective on technology adoption, market challenges, and regional dynamics shaping tissue diagnostics, empowering confident investment and procurement decisions.
  • Identify actionable strategies to strengthen supply chain resilience, ensure interoperability, and adapt product or service portfolios to shifting regulatory and competitive landscapes.
  • Leverage expert-led insights for long-term planning, resource allocation, and benchmarking in this rapidly evolving diagnostics sector.

Conclusion

The tissue diagnostics market is evolving through advances in digital pathology, molecular analysis, and integrated workflows. Leaders equipped with timely insights and agile strategies will be best positioned to drive operational excellence and meet the changing demands of global healthcare.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Tissue Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Analyzers & Scanners
8.2.2. Microscopes
8.3. Reagents & Kits
8.3.1. Dna/Rna Probes
8.3.2. Enzymes & Buffers
8.3.3. Staining Reagents
8.4. Services
8.4.1. Contract Research
8.4.2. Custom Assay Development
9. Tissue Diagnostics Market, by Application
9.1. Introduction
9.2. Cell Imaging & Analysis
9.2.1. Digital Image Analysis
9.2.2. Fluorescence Microscopy
9.3. Companion Diagnostics
9.3.1. Targeted Therapy Selection
9.3.2. Treatment Efficacy Monitoring
9.4. Infectious Disease
9.4.1. Bacterial Pathogen Detection
9.4.2. Viral Pathogen Detection
9.5. Tumor Profiling
9.5.1. Gene Expression Analysis
9.5.2. Mutation Detection
10. Tissue Diagnostics Market, by Technology
10.1. Introduction
10.2. Flow Cytometry
10.2.1. Automated Cytometers
10.2.2. Benchtop Cytometers
10.3. Immunohistochemistry
10.3.1. Chromogenic
10.3.2. Fluorescent
10.4. In Situ Hybridization
10.4.1. Cish
10.4.2. Fish
10.5. Microarray & Sequencing
10.5.1. Dna Microarray
10.5.2. Next-Generation Sequencing
11. Tissue Diagnostics Market, by End User
11.1. Introduction
11.2. Hospitals & Diagnostic Laboratories
11.2.1. Academic Hospitals
11.2.2. Community Labs
11.3. Pharmaceutical Companies
11.3.1. Biotech Firms
11.3.2. Large Pharma
11.4. Research Institutes
11.4.1. Government Labs
11.4.2. Private Research
12. Americas Tissue Diagnostics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Tissue Diagnostics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Tissue Diagnostics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Thermo Fisher Scientific Inc.
15.3.2. Danaher Corporation
15.3.3. Roche Diagnostics International AG
15.3.4. Agilent Technologies, Inc.
15.3.5. QIAGEN N.V.
15.3.6. Merck KGaA
15.3.7. Bio-Rad Laboratories, Inc.
15.3.8. Bio-Techne Corporation
15.3.9. Sakura Finetek U.S.A., Inc.
15.3.10. GE Healthcare UK Limited
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. TISSUE DIAGNOSTICS MARKET MULTI-CURRENCY
FIGURE 2. TISSUE DIAGNOSTICS MARKET MULTI-LANGUAGE
FIGURE 3. TISSUE DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. TISSUE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. TISSUE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TISSUE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ANALYZERS & SCANNERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY MICROSCOPES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DNA/RNA PROBES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ENZYMES & BUFFERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY STAINING REAGENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CONTRACT RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CUSTOM ASSAY DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DIGITAL IMAGE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY FLUORESCENCE MICROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TARGETED THERAPY SELECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TREATMENT EFFICACY MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BACTERIAL PATHOGEN DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY VIRAL PATHOGEN DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY GENE EXPRESSION ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY MUTATION DETECTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY AUTOMATED CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BENCHTOP CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CHROMOGENIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY FLUORESCENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY CISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY DNA MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY COMMUNITY LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY GOVERNMENT LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY PRIVATE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 67. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 68. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 69. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 87. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 88. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 89. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 90. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 92. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 93. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 94. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 95. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 97. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 100. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 102. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 103. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 104. UNITED STATES TISSUE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 105. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 107. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 108. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 109. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 111. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 112. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 113. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 114. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 116. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 117. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 118. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 119. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 121. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 122. CANADA TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 123. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 124. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 125. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 126. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 127. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 129. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 130. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 131. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 132. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 134. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 135. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 136. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 137. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 138. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 139. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 140. MEXICO TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 152. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 153. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 154. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 155. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 156. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 157. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 158. BRAZIL TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 159. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 160. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 161. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 162. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 163. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 165. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 166. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 167. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 168. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 170. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 171. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 172. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 173. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 174. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 175. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 176. ARGENTINA TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 196. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 198. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 199. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 200. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 202. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 204. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 208. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 210. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 212. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 214. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 215. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 216. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 217. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 218. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 220. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 221. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 222. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 223. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 225. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 226. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 227. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 228. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 229. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 230. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 231. GERMANY TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 232. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 233. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 234. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 235. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 236. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 238. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 239. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 240. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 241. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 243. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 244. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 245. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 246. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 247. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 248. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 249. FRANCE TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 250. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 251. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 252. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 253. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 254. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 256. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 257. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 258. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 259. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 261. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 262. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 263. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 264. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 266. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 267. RUSSIA TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 268. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 269. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 270. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 271. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 272. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 274. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 275. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 276. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 277. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 279. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 280. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 281. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 282. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 283. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 284. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 285. ITALY TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 286. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 288. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 289. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 290. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 291. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 292. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 293. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 294. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 295. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 297. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 298. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 299. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 300. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 301. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 302. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 303. SPAIN TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 304. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 305. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 306. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 307. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 308. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 309. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 310. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY COMPANION DIAGNOSTICS, 2018-2030 (USD MILLION)
TABLE 311. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASE, 2018-2030 (USD MILLION)
TABLE 312. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, 2018-2030 (USD MILLION)
TABLE 313. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 314. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY FLOW CYTOMETRY, 2018-2030 (USD MILLION)
TABLE 315. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2018-2030 (USD MILLION)
TABLE 316. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY IN SITU HYBRIDIZATION, 2018-2030 (USD MILLION)
TABLE 317. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY MICROARRAY & SEQUENCING, 2018-2030 (USD MILLION)
TABLE 318. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 319. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY HOSPITALS & DIAGNOSTIC LABORATORIES, 2018-2030 (USD MILLION)
TABLE 320. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
TABLE 321. UNITED ARAB EMIRATES TISSUE DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
TABLE 322. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 323. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 324. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY REAGENTS & KITS, 2018-2030 (USD MILLION)
TABLE 325. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 326. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 327. SAUDI ARABIA TISSUE DIAGNOSTICS MARKET SIZE, BY CELL IMAGING & ANALYSIS, 2018-2030 (USD MILLION)
TABLE 328. SAUDI ARABIA TISSUE DIAGNOSTICS MA

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Tissue Diagnostics market report include:
  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Roche Diagnostics International AG
  • Agilent Technologies, Inc.
  • QIAGEN N.V.
  • Merck KGaA
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Sakura Finetek U.S.A., Inc.
  • GE Healthcare UK Limited

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 9.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 14.03 Billion
Compound Annual Growth Rate7.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology (Immunohistochemistry, In Situ Hybridization), By Application (Breast Cancer), By Modality, By End-use (Hospital, Diagnostic Center), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Tissue Diagnostics Market Size, Share & Trends Analysis Report By Technology (Immunohistochemistry, In Situ Hybridization), By Application (Breast Cancer), By Modality, By End-use (Hospital, Diagnostic Center), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 171 Pages
  • Global
From
Tissue Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Tissue Diagnostics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 120 Pages
  • Global
From
Tissue Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Tissue Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 185 Pages
  • Global
From
Tissue Diagnostics - Global Strategic Business Report - Product Image

Tissue Diagnostics - Global Strategic Business Report

  • Report
  • 552 Pages
  • Global
From
Tissue Diagnostic Market Report 2025 - Product Image

Tissue Diagnostic Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.